REG - Craneware plc - Transaction in Own Shares

CranewareAnnouncement

Mon 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260323:nRSW5746Xa&default-theme=true

RNS Number : 5746X  Craneware plc  23 March 2026

23 March 2026

 

 Craneware plc

 ("Craneware", or the "Company")

 Transaction in Own Shares

Craneware (AIM: CRW.L), a leader in healthcare financial performance
solutions, announces it has purchased the following number of its Ordinary
Shares of 1p each through Peel Hunt LLP on the London Stock Exchange.

 Date of purchases:                                        16 to 20 March 2026
 Number of Ordinary Shares purchased (aggregated volume):  217,464
 Lowest price per share (pence):                           1,350.00
 Highest price per share (pence):                          1,440.00
 Weighted average price per day (pence):                   1,401.43

The Company will hold the purchased shares in Treasury. Following the purchase
of these shares, the Company will have 35,296,641 Ordinary Shares in issue
(excluding Treasury shares), and the Company will hold 245,528 Ordinary Shares
in Treasury.

The figure of 35,296,641 represents the total voting rights in the Company and
may be used by shareholders as the denominator for calculating whether they
are required to notify their interest in, or a change to their interest in,
the Company under the FCA's Disclosure Guidance and Transparency Rules.

The table below contains detailed information about the purchases made as part
of the buyback programme which was announced by the Company on 16 March 2026
(the "Programme").

 Aggregate information:

 

 Venue  Volume Weighted Average Price (p)  Aggregated Volume  Lowest price paid per share (p)  Highest price paid per share (p)
 AIMX   1,401.43                           217,464            1,350.00                         1,440.00

 

 Schedule of Purchases - Individual Transactions

In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No
596/2014 as it forms part of UK law, a full breakdown of the individual trades
made by Peel Hunt LLP on behalf of the Company as part of the Programme is
detailed below:

 Number of shares purchased  Transaction price (pence)  Venue  Time of each trade   Transaction Reference Number
 2,000                       1,420.00                   AIMX   16-03-2026 08:07:23  00190772727TRLO0
 17,349                      1,415.00                   AIMX   16-03-2026 08:15:34  00190774544TRLO0
 4,000                       1,420.00                   AIMX   16-03-2026 11:01:56  00190796732TRLO0
 6,104                       1,400.00                   AIMX   16-03-2026 11:49:54  00190801719TRLO0
 5,000                       1,435.00                   AIMX   16-03-2026 13:01:04  00190807168TRLO0
 8,099                       1,430.00                   AIMX   16-03-2026 14:20:57  00190819433TRLO0
 10,000                      1,430.00                   AIMX   17-03-2026 08:52:15  00190855206TRLO0
 5,000                       1,430.00                   AIMX   17-03-2026 09:04:56  00190856491TRLO0
 5,000                       1,430.00                   AIMX   17-03-2026 09:06:23  00190856667TRLO0
 5,000                       1,420.00                   AIMX   17-03-2026 09:09:46  00190856934TRLO0
 5,000                       1,425.00                   AIMX   17-03-2026 10:40:42  00190865992TRLO0
 5,000                       1,435.00                   AIMX   17-03-2026 15:15:23  00190895269TRLO0
 5,000                       1,440.00                   AIMX   17-03-2026 15:26:25  00190896972TRLO0
 3,430                       1,435.00                   AIMX   17-03-2026 15:32:57  00190898072TRLO0
 25,000                      1,430.00                   AIMX   18-03-2026 10:14:33  00190928506TRLO0
 19,845                      1,440.00                   AIMX   18-03-2026 12:50:28  00190943545TRLO0
 10,000                      1,375.00                   AIMX   19-03-2026 09:35:53  00190995893TRLO0
 5,000                       1,372.86                   AIMX   19-03-2026 10:43:47  00191004517TRLO0
 5,000                       1,380.00                   AIMX   19-03-2026 10:44:37  00191004680TRLO0
 10,000                      1,370.00                   AIMX   19-03-202613:01:14   00191023339TRLO0
 10,000                      1,360.00                   AIMX   19-03-2026 15:55:50  00191055153TRLO0
 3,466                       1,355.00                   AIMX   19-03-2026 16:24:30  00191059795TRLO0
 10,000                      1,365.00                   AIMX   20-03-2026 08:49:09  00191072321TRLO0
 10,000                      1,350.00                   AIMX   20-03-2026 10:23:11  00191081855TRLO0
 5,000                       1,350.00                   AIMX   20-03-2026 12:29:25  00191092329TRLO0
 18,171                      1,350.00                   AIMX   20-03-2026 13:32:57  00191097215TRLO0

 

 For further information please contact:

 

 Craneware plc                                    +44 (0)131 550 3100
 Keith Neilson, CEO
 Craig Preston, CFO

 Alma Strategic Communications                    +44 (0)20 3405 0205
 Caroline Forde, Kinvara Verdon, Louisa El-Ahwal  craneware@almastrategic.com

 Peel Hunt (NOMAD and Joint Broker)               +44 (0)20 7418 8900
 Neil Patel, Benjamin Cryer, Kate Bannatyne

 

About Craneware

 

For over 25 years, The Craneware Group (AIM:CRW.L) has been a leader in
healthcare financial and operational transformation, delivering cutting-edge
technologies that drive measurable impact. Our Trisus(®) cloud ecosystem
unifies data, revenue intelligence, margin intelligence, and advanced
analytics, enabling healthcare organizations to optimize performance, improve
financial sustainability, and drive strategic growth. As a trusted Microsoft
partner, we provide future-ready solutions-including the Best in KLAS Trisus
Chargemaster - that simplify the complexities of healthcare finance and
operations. What sets us apart is our unique combination of deep healthcare
expertise and engineering excellence, positioning us as a strategic partner
rather than just a technology provider. The Craneware Group empowers
healthcare organizations to achieve sustainable financial success while
delivering better outcomes for the communities they serve - today and in the
future. Together, we are transforming the business of healthcare.

Learn more at www.thecranewaregroup.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  POSPPUWUWUPQGBU



            Copyright 2019 Regulatory News Service, all rights reserved